Cardiac protein phosphorylation: functional and pathophysiological correlates

被引:57
作者
Rapundalo, ST [1 ]
机构
[1] Warner Lambert Parke Davis, Div Pharmaceut Res, Dept Biochem, Ann Arbor, MI 48105 USA
关键词
phosphoproteins; regulatory proteins; protein kinases; protein phosphatases; dephosphorylation; excitation-contraction coupling;
D O I
10.1016/S0008-6363(98)00063-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protein phosphorylation acts a pivotal mechanism in regulating the contractile state of the heart by modulating particular levels of autonomic control on cardiac force/length relationships. Early studies of changes in cardiac protein phosphorylation focused on key components of the excitation-coupling process, namely phospholamban of the sarcoplasmic reticulum and myofibrillar troponin I. In more recent years the emphasis has shifted towards the identification of other phosphoproteins, and more importantly, the delineation of the mechanistic and signaling pathways regulating the various known phosphoproteins. In addition to cAMP- and Ca2+-calmodulin-dependent kinase processes, these have included regulation by protein kinase C and the ever-emerging family of growth factor-related kinases such as the tyrosine-, mitogen- and stress-activated protein kinases. Similarly, the role of protein dephosphorylation by protein phosphatases has been recognized as integral in modulating normal cardiac cellular function. Recent studies involving a variety of cardiovascular pathologies have demonstrated that changes in the phosphorylation states of key cardiac regulatory proteins may underlie cardiac dysfunction in disease states. The emphasis of this comprehensive review will be on discussing the role of cardiac phosphoproteins in regulating myocardial function and pathophysiology based not only on in vitro data, but more importantly, from ex vivo experiments with corroborative physiological and biochemical evidence. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:559 / 588
页数:30
相关论文
共 350 条
[1]   COMPUTATIONAL SEARCHING AND MUTAGENESIS SUGGEST A STRUCTURE FOR THE PENTAMERIC TRANSMEMBRANE DOMAIN OF PHOSPHOLAMBAN [J].
ADAMS, PD ;
ARKIN, IT ;
ENGELMAN, DM ;
BRUNGER, AT .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (02) :154-162
[2]  
AHMAD Z, 1989, J BIOL CHEM, V264, P3859
[3]  
Allen BG, 1996, MOL CELL BIOCHEM, V155, P91
[4]  
ANGELOS KL, 1987, J BIOL CHEM, V262, P3219
[5]   Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes [J].
Antipenko, AY ;
Spielman, AI ;
Sassaroli, M ;
Kirchberger, MA .
BIOCHEMISTRY, 1997, 36 (42) :12903-12910
[6]   Structural perspectives of phospholamban, a helical transmembrane pentamer [J].
Arkin, IT ;
Adams, PD ;
Brunger, AT ;
Smith, SO ;
Engelman, DM .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1997, 26 :157-179
[7]   EFFECTS OF THE PROTEIN PHOSPHATASE INHIBITORS OKADAIC ACID AND CALYCULIN-A ON METABOLICALLY INHIBITED AND ISCHEMIC ISOLATED MYOCYTES [J].
ARMSTRONG, SC ;
GANOTE, CE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 (08) :869-884
[8]   Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes [J].
Armstrong, SC ;
Hoover, DB ;
Delacey, MH ;
Ganote, CE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1996, 28 (07) :1479-1492
[9]   Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: Effects of a protein phosphatase inhibitor, fostriecin [J].
Armstrong, SC ;
Kao, R ;
Gao, W ;
Shivell, LC ;
Downey, JM ;
Honkanen, RE ;
Ganote, CE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (11) :3009-3024
[10]   THE PROTEIN ISK IS A DUAL ACTIVATOR OF K+ AND CL- CHANNELS [J].
ATTALI, B ;
GUILLEMARE, E ;
LESAGE, F ;
HONORE, E ;
ROMEY, G ;
LAZDUNSKI, M ;
BARHANIN, J .
NATURE, 1993, 365 (6449) :850-852